Erratum to "Gene therapy in orthopaedics" [Injury 2006; 37(1S): S30-40] (DOI:10.1016/j.injury.2006.02.038);Gene therapy in orthopaedics

Injury

Volumn 37, Issue 1, 2006, Pages 926-

  Giannoudis, Peter V ^a   Tzioupis, Christopher C ^a   Tsirids, Eleftherios ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Cartilage repair; Fracture healing; Gene therapy; Orthopaedics

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; COLONY STIMULATING FACTOR 1; DNA; FOCAL ADHESION KINASE; GROWTH FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 4; LENTIVIRUS VECTOR; LIGAND; LIM PROTEIN; LIPOSOME; NEUROMODULIN; OSTEOGENIC PROTEIN 1; PARVOVIRUS VECTOR; PEPTIDE; PLASMID DNA; PLATELET DERIVED GROWTH FACTOR; PROCOLLAGEN; RECOMBINANT PROTEIN; RETROVIRUS VECTOR; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VASCULOTROPIN; VIRUS VECTOR;

ARTICLE; ARTICULAR CARTILAGE; BONE DISEASE; BONE REGENERATION; BONE REMODELING; CANCER; CANCER CHEMOTHERAPY; CARTILAGE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; FRACTURE HEALING; GENE DELIVERY SYSTEM; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENE VECTOR; HERPES SIMPLEX VIRUS; HUMAN; INTERVERTEBRAL DISK; KNEE MENISCUS; LIGAMENT; METABOLIC BONE DISEASE; MOLECULAR GENETICS; MUSCULOSKELETAL SYSTEM; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; ONCOLOGY; ORTHOPEDICS; OSSIFICATION; OSTEOARTHRITIS; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SAFETY; SENSITIVITY ANALYSIS; SOMATIC GENE THERAPY; SPINAL CORD INJURY; SPINE FUSION; TENDON; TUMOR NECROSIS;

EID: 33646033766     PISSN: 00201383     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.injury.2006.05.002     Document Type: Erratum

References (95)

1. Abboud S.L., Woodruff K., Liu C., et al. Rescue of the osteopetrotic defect in op/op mice by osteoblast-specific targeting of soluble colony-stimulating factor-1. Endocrinology 143 (2002) 1942-1949
2. Alden T.D., Pittman D.D., Beres E.J., et al. Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy. J Neurosurg 90 (1999) 109-114
3. Anderson W.F. Human gene therapy. Science 256 (1992) 808-813
4. Anderson W.F. Human gene therapy. Nature 392 Suppl. 6679 (1998) 25-30 [review]
5. Arai Y., Kubo T., Kobayashi K., et al. Adenovirus vector-mediated gene transduction to chondrocytes: in vitro evaluation of therapeutic efficacy of transforming growth factor-b1 and heat shock protein 70 gene transduction. J Rheumatol 24 (1997) 1787-1795
6. Arnoczky S., and Warren R. The microvasculature of the meniscus and its response to injury. An experimental study in the dog. Am J Sports Med 11 (1983) 131-141
7. Baltzer A., Lattermann C., Whalen J., et al. Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Ther 7 (2000) 734-739
8. Benowitz L.I., and Routtenberg A. A membrane phosphoprotein associated with neural development, axonal regeneration, phospholipid metabolism, and synaptic plasticity. Trends Neurosci 10 (1987) 527-531
9. Blomer U., Naldini L., Kafri T., et al. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J Virol 71 (1997) 6641-6649
10. Boden S.D., Titus L., Hair G., et al. Lumbar spine fusion by local gene therapy with a cDNA encoding a novel osteoinductive protein (LMP-1). Spine 23 (1998) 2486-2492
11. Bonadio J. Tissue engineering via local gene delivery. J Mol Med 78 (2000) 303-311
12. Bonadio J., Goldstein S.A., and Levy R.J. Gene therapy for tissue repair and regeneration. Adv Drug Deliv Rev 33 (1998) 53-69
13. Bonadio J., Smiley E., Patil P., and Goldstein S. Localized, direct plasmid gene therapy in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med 5 (1999) 753-759
14. Breitbart A.S., Grande D.A., Mason J.M., et al. Gene-enhanced tissue engineering: applications for bone healing using cultured periosteal cells transduced retrovirally with the BMP-7 gene. Ann Plast Surg 42 (1999) 488-495
15. Bresnihan B., Alvaro-Garcia J.M., Cobby M., et al. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum 41 (1998) 2196-2204
16. Brittberg M., Lindahl A., Nilsson A., et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331 (1994) 889-895
17. Buchschacher Jr. G.L., and Panganiban A.T. Human immunodeficiency virus vectors for inducible expression of foreign genes. J Virol 66 (1992) 2731-2739
18. Buckwalter J., and Mankin H. Articular cartilage repair and transplantation. Arthritis Rheum 41 (1998) 1331-1342
19. Bulsara K.R., Iskandar B.J., Villavicencio A.T., and Skene J.H. A new millenium for spinal cord regeneration: growth-associated genes. Spine 27 (2002) 1946-1949
20. Carmody E.E., Schwarz E.M., Puzas J.E., et al. Viral interleukin-10 gene inhibition of inflammation, osteoclastogenesis, and bone resorption in response to titanium particles. Arthritis Rheum 46 (2002) 1298-1308
21. Cattermole H., Hardy J., and Gregg P. The footballer's fracture. Br J Sports Med 30 (1996) 171-175
22. Chen Y. Orthopedic applications of gene therapy. J Orthop Sci 6 (2001) 199-207
23. Crystal R.G. Transfer of genes to humans: early lessons and obstacles to success. Science 270 (1995) 404-410
24. Culver K.W. In: Culver K.W. (Ed). Gene therapy. A primer for physicians. 2nd ed. (1996), Mary Ann Liebert, Larchmont, NY
25. Davis M.E. Non-viral gene delivery systems. Curr Opin Biotechnol 13 (2002) 128-131
26. Dodig M., Tadic T., Kronenberg M.S., et al. Ectopic Msx2 overexpression inhibits and Msx2 antisense stimulates calvarial osteoblast differentiation. Dev Biol 209 (1999) 298-307
27. Egermann M., Schneider E., Evans C.H., and Baltzer A.W. The potential of gene therapy for fracture healing in osteoporosis. Osteoporos Int 16 Suppl. 2 (2005) S120-S128
28. Evans C.H., Ghivizzani S.C., Herndon J.H., and Robbins P.D. Gene therapy for the treatment of musculoskeletal diseases. J Am Acad Orthop Surg 13 (2005) 230-242
29. Evans C.H., Ghivizzani S.C., and Oligino T.J. Gene therapy for autoimmune disorders. J Clin Immunol 20 (2000) 334-346
30. Evans C.H., and Robbins P.D. Possible orthopaedic applications of gene therapy. J Bone Joint Surg 77A (1995) 1103-1114
31. Evans C.H., Robbins P.D., Ghivizzani S.C., et al. Clinical trial to assess the safety, feasibility and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum Gene Ther 7 (1996) 1261-1280
32. Fang J., Zhu Y.Y., Smiley E., et al. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci USA 93 (1996) 5753-5758
33. Fellowes R., Etheridge C.J., Coade S., et al. Amelioration of established collagen-induced arthritis by systemic IL-10 gene delivery. Gene Ther 7 (2000) 967-977
34. Fernandes J., Tardif G., Martel-Pelletier J., et al. In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints. Am J Pathol 154 (1999) 1159-1169
35. Fiorellini J.P., Buser D., Riley E., and Howell T.H. Effect on bone healing of bone morphogenetic protein placed in combination with endosseous implants: a pilot study in beagle dogs. Int J Periodont Restor Dent 21 (2001) 41-47
36. Geiler T., Kriegsmann J., Keyszer G.M., et al. A new model for rheumatoid arthritis generated by engraftment of rheumatoid synovial tissue and normal human cartilage into SCID mice. Arthritis Rheum 37 (1994) 1664-1671
37. Goater J., Muller R., Kollias G., et al. Empirical advantages of adeno-associated viral vectors for in vivo gene therapy for arthritis. J Rheumatol 27 (2000) 983-989
38. Goto H., Shuler F.D., Niyibizi C., et al. Gene therapy for meniscal injury: enhanced synthesis of proteoglycan and collagen by meniscal cells transduced with a TGFbeta(1) gene. Osteoarthritis Cartilage 8 (2000) 266-271
39. Grande D.A., Mason J., Light E., and Dines D. Stem cells as platforms for delivery of genes to enhance cartilage repair. J Bone Joint Surg Am 85 Suppl. 2 (2003) 111-116
40. Haecker S.E., Stedman H.H., Balice-Gordon R.J., et al. In vivo expression of full-length human dystrophin from adrenoviral vectors deleted of all viral genes. Hum Gene Ther 7 (1996) 1907-1914
41. Hannallah D., Peterson B., Lieberman J.R., et al. Gene therapy in orthopaedic surgery. Instr Course Lect 52 (2003) 753-768
42. Herkowitz H.N. Lumbar spinal stenosis: indications for arthrodesis and spinal instrumentation. Instr Course Lect 43 (1994) 425-433
43. Hidaka C., Khan S.N., Farmer J.C., and Sandhu H.S. Gene therapy for spinal applications. Orthop Clin N Am 33 April (2) (2002) 439-446
44. Hope M.J., Mui B., Ansell S., and Ahkong Q.F. Cationic lipids, phosphatidylethanolamine and the intracellular delivery of polymeric, nucleic acid-based drugs. Mol Membr Biol 15 (1998) 1-14 [review]
45. Jones L.L., Oudega M., Bunge M.B., and Tuszynski M.H. Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury. J Physiol 533 (2001) 83-89 [review]
46. Kafri T., Blomer U., Peterson D.A., et al. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 17 (1997) 314-317
47. Kaji E.H., and Leiden J.M. Gene and stem cell therapies. JAMA 285 (2001) 545-550
48. Kang R., Ghivizzani S.C., Muzzonigro T.S., et al. Orthopaedic applications of gene therapy: from concept to clinic. Clin Orthop Relat Res 375 (2000) 324-337
49. Klamut H.J., Chen S.T., Lau K.H., and Baylink D.J. Progress toward skeletal gene therapy. Crit Rev Eukaryot Gene Expr 14 1-2 (2004) 89-136
50. Klein R.M., Wolf E.D., Wu R., and Sanford J.C. High-velocity microprojectiles for delivering nucleic acids into living cells. Nature 327 (1987) 70-75
51. Kobayashi T., Okamoto K., Kobata T., et al. Novel gene therapy for rheumatoid arthritis by FADD gene transfer: induction of apoptosis of rheumatoid synoviocytes but not chondrocytes. Gene Ther 7 (2000) 527-533
52. Kubo T., Takahashi K., and Hirasawa Y. Gene therapies for joint diseases. Mod Rheumatol 11 (2001) 10-16
53. Kuiper S., Joosten L.A., Bendele A.M., et al. Different roles of tumor necrosis factor alpha and interleukin 1 in murine streptococcal cell wall arthritis. Cytokine 10 (1998) 690-702
54. Li H., Zou X., and Bunger C. Gene therapy and spinal disorders. Int Orthop 25 (2001) 1-4
55. Lind M., and Bunger C. Orthopaedic applications of gene therapy. Int Orthop 29 4 (2005) 205-209
56. Lou J., Kubota H., Hotokezaka S., et al. In vivo gene transfer and overexpression of focal adhesion kinase (pp125 FAK) mediated by recombinant adenovirus-induced tendon adhesion formation and epitenon cell change. J Orthop Res 15 (1997) 911-918
57. Lubberts E., Joosten L.A.B., Chabaud M., et al. IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion. J Clin Invest 105 (2000) 1697-1710
58. Mankin H. The response of articular cartilage to mechanical injury. J Bone Joint Surg Am 64 (1982) 460-466
59. Martinek V., Latterman C., Usas A., et al. Enhancement of tendon-bone integration of anterior cruciate ligament grafts with bone morphogenetic protein-2 gene transfer. J Bone Joint Surg Am 84-A (2002) 1123-1131
60. Mason J., Grande D., Barcia M., et al. Expression of human bone morphogenic protein 7 in primary rabbit periosteal cells: potential utility in gene therapy for osteochondral repair. Gene Ther 5 (1998) 1098-1104
61. Mehrara B.J., Saadeh P.B., Steinbrech D.S., et al. Adenovirus-mediated gene therapy of osteoblasts in vitro and in vivo. J Bone Miner Res 14 (1999) 1290-1301
62. Miller A.D. Human gene therapy comes of age. Nature 357 (1992) 455-460
63. Miyasaka K., Daniel D., and Hirschman P. The incidence of knee ligament injuries in the general population. Am J Knee Surg 4 (1991) 3-8
64. Nakamura N., Shino K., Natsuume T., et al. Early biological effect of in vivo gene transfer of platelet-derived growth factor (PDGF)-B into healing patellar ligament. Gene Ther 5 (1998) 1165-1170
65. Naldini L., Blomer U., Gallay P., et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272 (1996) 263-267
66. Nishida K., Kang J.D., Suh J.K., et al. Adenovirusmediated gene transfer to nucleus pulposus cells. Implications for the treatment of intervertebral disc degeneration. Spine 23 (1998) 2437-2442
67. Niyibizi C., Baltzer A., Latterman C., et al. Potential role for gene therapy in the enhancement of fracture healing. Clin Orthop Relat Res 355S (1998) S148-S153
68. Niyibizi C., Smith P., Mi Z., et al. Transfer of proalpha2(I) cDNA into cells of a murine model of human osteogenesis imperfecta restores synthesis of type I collagen comprised of alpha1(I) and alpha2(I) heterotrimers in vitro and in vivo. J Cell Biochem 83 (2001) 84-91
69. Okamoto K., Asahara H., Kobayashi T., et al. Induction of apoptosis in the rheumatoid synovium by Fas-ligand gene transfer. Gene Ther 5 (1998) 331-338
70. Oligino T., Ghivizzani S.C., Wolfe D., et al. Intra-articular delivery of a herpes simplex virus IL-1Ra gene vector reduces inflammation in a rabbit model of arthritis. Gene Ther 6 (1999) 1713-1720
71. Oreffo R.O., Virdi A.S., and Triffitt J.T. Retroviral marking of human bone marrow fibroblasts: in vitro expansion and localization in calvarial sites after subcutaneous transplantation in vivo. J Cell Physiol 186 (2001) 201-209
72. Otani K., Nita I., Macaulay W., et al. Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy. J Immunol 156 (1996) 3558-3562
73. Peng H., Wright V., Usas A., et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110 (2002) 751-759
74. Ramnaraine M., Pan W., Goblirsch M., et al. Direct and bystander killing of sarcomas by novel cytosine deaminase fusion gene. Cancer Res 63 (2003) 6847-6854
75. Riew K.D., Wright N.M., Cheng S., et al. Induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene in a rabbit spinal fusion model. Calcif Tissue Int 63 (1998) 357-360
76. Sandhu H.S., Grewal H.S., and Parvataneni H.K. Bone grafting for spinal fusion. Orthop Clin N Am 30 (1999) 685-698
77. Simons M., Bonow R.O., Chronos N.A., et al. Clinical trials in coronary angiogenesis: issues, problems, consensus. An expert panel summary. Circulation 102 (2000) E73-E86 [review]
78. Smith P., Shuler F.D., Georgescu H.I., et al. Genetic enhancement of matrix synthesis by articular chondrocytes: comparison of different growth factor genes in the presence and absence of interleukin-1. Arthritis Rheum 43 (2000) 1156-1164
79. Song X., Gu M., Jin W., et al. Plasmid DNA encoding transforming growth factor-b1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model. J Clin Invest 101 (1998) 2615-2621
80. Southwood L.L., Frisbie D.D., Kawcak C.E., and McIlwraith C.W. Delivery of growth factors using gene therapy to enhance bone healing. Vet Surg 33 (2004) 565-578
81. Steinert A.F., Palmer G.D., and Evans C.H. Gene therapy in the musculoskeletal system. Curr Opin Orthop 15 (2004) 318-324
82. Thomas C.E., Ehrhardt A., and Kay M.A. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 4 (2003) 346-358
83. Tomita T., Hashimoto H., Tomita N., et al. In vivo direct gene transfer into articular cartilage by intraarticular injection mediated by HVJ (Sendai virus) and liposomes. Arthritis Rheum 40 (1997) 901-906
84. Turgeman G., Pittman D.D., Muller R., et al. Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy. J Gene Med 3 (2001) 240-251
85. Ulrich-Vinther M., Carmody E.E., Goater J.J., et al. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. J Bone Joint Surg Am 84-A (2002) 1405-1412
86. van Griensven M., Lobenhoffer P., Barke A., et al. Adenoviral gene transfer in a rat fracture model. Lab Anim 36 (2002) 455-461
87. Varady P., Li J.Z., Cunningham M., et al. Morphologic analysis of BMP-9 gene therapy-induced osteogenesis. Hum Gene Ther 12 (2001) 697-710
88. Watanabe S., Kim K.-N., Imagawa T., et al. On the mechanism of protection of distal joints after local gene transfer in collagen-induced arthritis. Hum Gene Ther 11 (2000) 751-758
89. Wehling P., Schulitz K.P., Robbins P.D., et al. Transfer of genes to chondrocytic cells of the lumbar spine. Proposal for a treatment strategy of spinal disorders by local gene therapy. Spine 22 (1997) 1092-1097
90. Wilson J.M. Adenoviruses as gene-delivery vehicles. N Engl J Med 334 (1996) 1185-1187 [review]
91. Wooley P.H., Whalen J.D., Chapman D.L., et al. The effect of an interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice. Arthritis Rheum 36 (1993) 1305-1314
92. Wu D., Razzano P., and Grande D.A. Gene therapy and tissue engineering in repair of the musculoskeletal system. J Cell Biochem 88 (2003) 467-481
93. Wu X., Li Y., Crise B., and Burgess S.M. Transcription start regions in the human genome are favored targets for MLV integration. Science 300 (2003) 1749-1751
94. Yang S., Wu B., Mayton L., et al. IL-1Ra and vIL-10 gene transfer using retroviral vectors ameliorates particle-associated inflammation in the murine air pouch model. Inflamm Res 51 (2002) 342-350
95. Yao Q., Glorioso J.C., Evans C.H., et al. Adenoviral-mediated delivery of Fas-ligand to arthritic joints caused extensive apoptosis in the synovial lining. J Gene Med 2 (2000) 210-219